MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 154 filers reported holding MERSANA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $42 | -44.7% | 12,869 | -30.2% | 0.01% | -28.6% |
Q1 2023 | $76 | -47.2% | 18,437 | -24.8% | 0.01% | -50.0% |
Q4 2022 | $144 | -99.9% | 24,533 | -22.6% | 0.01% | -33.3% |
Q3 2022 | $214,000 | +122.9% | 31,698 | +52.1% | 0.02% | +90.9% |
Q2 2022 | $96,000 | +41.2% | 20,836 | +22.4% | 0.01% | +37.5% |
Q1 2022 | $68,000 | -66.7% | 17,027 | -48.2% | 0.01% | -65.2% |
Q4 2021 | $204,000 | -24.2% | 32,871 | +65.8% | 0.02% | -14.8% |
Q2 2021 | $269,000 | +195.6% | 19,821 | +27.7% | 0.03% | +50.0% |
Q1 2020 | $91,000 | +378.9% | 15,524 | +31.9% | 0.02% | +500.0% |
Q3 2019 | $19,000 | – | 11,772 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |